Thorac Cardiovasc Surg 2011; 59 - V104
DOI: 10.1055/s-0030-1269077

Safety of bilateral internal thoracic artery (BITA) revascularisation for the elderly patients

A Beiras-Fernandez 1, F Kur 1, S Michel 1, M Wolf 1, S Sadoni 1, E Kilger 2, B Reichart 1, C Vicol 1
  • 1Herzchirurgische Klinik; LM-Universität, München, Germany
  • 2Klinik für Anästhesiologie; LM-Universität, München, Germany

Aims: Bilateral internal thoracic artery (BITA) grafting is associated with a long-term survival advantage. However, BITA grafting has traditionally been performed in young patients presenting with coronary artery disease, and some studies have defined 60-years as cut-off point for its beneficial effect. Our aim was to assess the safety of BITA in patients >65 years in comparison to younger patients on terms of quality of life (QOL) and mid-term outcome.

Methods: A retrospective analysis was performed comparing 184 consecutive patients <65 years [mean age:56±2 y; 89.7% male] receiving BITA and supplemental vein grafts with 142 consecutive patients older than 65 years [mean age:72±3 y; 77.4% male] operated within the same period. Preoperative risk factors and operative data, such as technique, and number of grafts were analyzed. Postoperative complications, and need for reoperation/intervention were assessed. A modified SF-36 quality of life (QOL) questionnaire was completed at follow-up [85% patients; mean 36 months].

Results: Patients>65 had more diabetes and kidney insufficiency, while patients<65 had more hypercholesterolemia and smoking. No differences regarding ejection fraction, intraoperative data and postoperative complications were recorded. Although the in-hospital survival was comparable, patients>65 showed a longer hospital stay [13.8d vs. 11.9d; p=0.01]. At follow-up, freedom from angina, and need for reoperation/intervention was similar for both groups; however, the patients>65 showed a significant lower QOL, and a lower non-adjusted survival [91.6% vs. 98.6%; p=0.006]

Conclusions: BITA revascularisation in patients >65 seems a safe surgical option regarding 30-day survival and operative outcome. However, patients >65 present a lower mid-term survival and QOL.